Medicare Enrolled
Dr. Constance Gore, APN
Acute Care Nurse Practitioner · Morristown, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gore?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gore
Dr. Constance Gore is an acute care nurse practitioner in Morristown, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gore performed 103,109 Medicare services across 1,485 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gore received a total of $3,413 from 14 pharmaceutical and/or device companies across 35 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in acute care nurse practitioner. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gore is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in NJ
$3,413 industry payments
Medicare Practice Summary
Medicare Utilization ↗103,109
Medicare services
Top 0% in NJ for acute care nurse practitioner
1,485
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,155 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
30,000 | $1 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
27,501 | $2 | $6 |
| Denosumab injection (Prolia/Xgeva) | 10,680 | $17 | $32 |
| Pembrolizumab injection (Keytruda) | 9,800 | $38 | $88 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
6,120 | $38 | $79 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
4,400 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 3,900 | $1 | $4 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,771 | $0 | $2 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,400 | $36 | $76 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,081 | $1 | $7 |
| Injection, leucovorin calcium, per 50 mg | 1,020 | $3 | $6 |
| Anti-nausea injection (ondansetron/Zofran) | 636 | $0 | $1 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
632 | $10 | $72 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
609 | $2 | $4 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
420 | $87 | $301 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
378 | $12 | $103 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
304 | $100 | $597 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
175 | $1 | $5 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
110 | $48 | $240 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
95 | $129 | $366 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
90 | $26 | $121 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
79 | $1 | $1 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
73 | $41 | $116 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 70 | $135 | $413 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
64 | $47 | $290 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
61 | $135 | $583 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
60 | $22 | $159 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
59 | $57 | $228 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
57 | $15 | $111 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
54 | $8 | $15 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
54 | $22 | $131 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
41 | $80 | $422 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
38 | $7 | $89 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $91 | $274 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
37 | $1 | $11 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
32 | $24 | $211 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
32 | $15 | $88 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
29 | $15 | $92 |
| New patient office visit, complex (60-74 min) | 27 | $159 | $516 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
26 | $44 | $242 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
26 | $2 | $4 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
19 | $58 | $274 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
11 | $60 | $188 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.8% high complexity
69.8% medium
0.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,413
Total received (2021-2024)
Avg $853/year across 4 years
Top 7% in NJ for acute care nurse practitioner
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
14
Companies
35
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,005 (88.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$409 (12.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$749
2023
$1,007
2022
$589
2021
$1,068
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$409
Janssen Biotech, Inc.
$233
Daiichi Sankyo Inc.
$108
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2021-2024) ›
Myriad Genetic Laboratories, Inc.
$779
AstraZeneca Pharmaceuticals LP
$680
Seagen Inc.
$467
Janssen Biotech, Inc.
$444
Daiichi Sankyo Inc.
$273
GlaxoSmithKline, LLC.
$122
Averitas Pharma Inc.
$120
CTI BioPharma Corp.
$117
E.R. Squibb & Sons, L.L.C.
$108
Astellas Pharma US Inc
$100
AbbVie Inc.
$96
Exelixis Inc.
$70
Neurocrine Biosciences, Inc.
$20
Eisai Inc.
$17
Top 3 companies account for 56.4% of all-time payments
Associated products mentioned in payments ›
CALQUENCE · Cabometyx · DARZALEX · Enhertu · INGREZZA · LYNPARZA · Lenvima · MYRISK · PADCEV · PRECISETUMOR · QUTENZA · REBLOZYL · TAGRISSO · TALVEY · TUKYSA · VENCLEXTA · Vonjo · ZEJULA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for acute care nurse practitioner in NJ.
Geographic Context
Acute care nurse practitioners within 10 mi
377
Per 100K population
73.9
County median income
$134,929
Nearest hospital
GREYSTONE PARK PSYCHIATRIC HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gore is a mixed practice specialist, with above-average Medicare volume (top 0% in NJ), with low-engagement industry engagement in the top 7% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gore experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Gore performed 30,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gore receive payments from pharmaceutical companies?
Yes. Dr. Gore received a total of $3,413 from 14 companies across 35 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gore's costs compare to other acute care nurse practitioners in Morristown?
Dr. Gore's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Acute Care Nurse Practitioners in Morristown
Browse acute care nurse practitioners in Morristown ranked by procedure volume and transparency data.
Highest volume
Top Acute Care Nurse Practitioners in NJ
Acute care nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Acute Care Nurse Practitioners in NJ
Which NJ acute care nurse practitioners receive the most from drug and device companies.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology